284 related articles for article (PubMed ID: 23521455)
1. Glomerular filtration rate in evaluation of the effect of iodinated contrast media on renal function.
Becker J; Babb J; Serrano M
AJR Am J Roentgenol; 2013 Apr; 200(4):822-6. PubMed ID: 23521455
[TBL] [Abstract][Full Text] [Related]
2. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.
Ladwig M; Flemming B; Seeliger E; Sargsyan L; Persson PB
Invest Radiol; 2011 Nov; 46(11):672-7. PubMed ID: 21623210
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
Schönefeld E; Höwler S; Osada N; Torsello G
Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography.
Sandstede JJ; Roth A; Machann W; Kaupert C; Hahn D
Eur J Radiol; 2007 Jul; 63(1):120-3. PubMed ID: 17317065
[TBL] [Abstract][Full Text] [Related]
7. Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in Neonates.
Bedoya MA; White AM; Edgar JC; Pradhan M; Raab EL; Meyer JS
Radiology; 2017 Aug; 284(2):530-540. PubMed ID: 28387639
[TBL] [Abstract][Full Text] [Related]
8. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
[TBL] [Abstract][Full Text] [Related]
9. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
[TBL] [Abstract][Full Text] [Related]
10. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
[TBL] [Abstract][Full Text] [Related]
11. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography.
Breglia A; Godi I; Virzì GM; Guglielmetti G; Iannucci G; De Cal M; Brocca A; Carta M; Giavarina D; Ankawi G; Passannante A; Yun X; Biolo G; Ronco C
Cardiorenal Med; 2020; 10(2):125-136. PubMed ID: 32036364
[TBL] [Abstract][Full Text] [Related]
12. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients.
Erley CM; Bader BD; Berger ED; Tuncel N; Winkler S; Tepe G; Risler T; Duda S
Nephrol Dial Transplant; 2004 Oct; 19(10):2526-31. PubMed ID: 15280530
[TBL] [Abstract][Full Text] [Related]
14. Comparative investigation of i.v. iohexol and iopamidol: effect on renal function in low-risk outpatients undergoing CT.
Dillman JR; al-Hawary M; Ellis JH; Cohan RH; Kaza R; Myles JD; Khalatbari S; Francis IR
AJR Am J Roentgenol; 2012 Feb; 198(2):392-7. PubMed ID: 22268183
[TBL] [Abstract][Full Text] [Related]
15. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
Kuhn MJ; Chen N; Sahani DV; Reimer D; van Beek EJ; Heiken JP; So GJ
AJR Am J Roentgenol; 2008 Jul; 191(1):151-7. PubMed ID: 18562739
[TBL] [Abstract][Full Text] [Related]
16. Calculation of glomerular filtration rate in conscious rats by the use of a bolus injection of iodixanol and a single blood sample.
Katayama R; Yamaguchi N; Yamashita T; Watanabe S; Satoh H; Yamagishi N; Furuhama K
J Pharmacol Toxicol Methods; 2010; 61(1):59-64. PubMed ID: 19854282
[TBL] [Abstract][Full Text] [Related]
17. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
Karlsberg RP; Dohad SY; Sheng R;
J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
[TBL] [Abstract][Full Text] [Related]
18. Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization.
Artunc FH; Fischer IU; Risler T; Erley CM
Int J Cardiol; 2005 Jul; 102(2):173-8. PubMed ID: 15982481
[TBL] [Abstract][Full Text] [Related]
19. Is the use of intravenous contrast material truly safe in patients with impaired renal function?
Cohen MD
Radiology; 2009 May; 251(2):613; author reply 613-4. PubMed ID: 19401587
[No Abstract] [Full Text] [Related]
20. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
